Header Logo

Connection

Philip Bonomi to Nogalamycin

Back to Details
This is a "connection" page, showing publications Philip Bonomi has written about Nogalamycin.
Philip Bonomi
Connection Strength
0.110
Nogalamycin
  1. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study. J Natl Cancer Inst. 1992 Jul 15; 84(14):1077-84.
    View in: PubMed
    Score: 0.110
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.